P I Industries Ltd (PIIND) is currently trading at 2,253.70 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

PI Industries is an integrated agri‑sciences and life‑sciences company focused on custom synthesis & manufacturing (CSM) for global innovators, domestic branded agrochemicals and emerging platforms in biologicals, pharma CRDMO and electronic chemicals, supported by large R&D facilities, five multi‑purpose plants and global commercial offices across 40+ countries. Q3 FY26 showed near‑term demand softness with consolidated revenue down 28% QoQ to INR 13,757 million, but gross margin improved to 59% and 9M EBITDA margin stayed resilient at 27%, reflecting favourable product mix, cost discipline and disciplined investment even as volumes were delayed by customer phasing and weak market conditions. PI Industries is investing aggressively for growth: INR 7,225 million capex in 9M FY26 (three MPPs under construction), planned FY27 capex of INR 500–600 crore, a debt‑free balance sheet with surplus cash of ~INR 35,066 million and an order book of roughly USD 1.2 billion supporting near‑term capacity utilisation plans. The company is transforming into a LifeSciences platform: biological peptide tech, commercial approvals (Harpinαβ, Obrona), a pharma CRDMO push with 50% 9M revenue growth, and electronic chemicals commercialisation — signalling PI Industries’ pivot to higher‑value, IP‑backed products built on 700+ scientists and 250+ patents.

Over the past 52 weeks, P I Industries Ltd has traded between a low of ₹2,193.60 and a high of ₹3,829.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

P I Industries Ltd has a market capitalization of approximately 34,250.37. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

P I Industries Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 29.40 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 34,250.37 Cr, P I Industries Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

P I Industries Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of P I Industries Ltd is 29.40. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The earnings call was held on August 12, 2026, and it covered unaudited results for the quarter ended June 30, 2026.

PI Industries trades as PIIND on NSE and 523642 on BSE, as shown in the provided data.

For FY26 ended March 31, 2026, PI Industries reported consolidated revenue from operations of ₹67,137 million and consolidated PAT of ₹13,208 million.

The ₹10,000 crore initiative directly supports P I Industries' growing pharma custom synthesis business by fostering a robust domestic ecosystem for R&D, manufacturing, and clinical trials, which can attract more global projects.